×
App Icon
The Standard e-Paper
Join Thousands Daily
★★★★ - on Play Store
Download App

Drug that shortens recovery time for Covid-19 patients to be availed in Kenya

Indian firm Cipla will distribute remdesivir in Kenya, an antiviral drug that could be critical in the management of Covid-19.

Cipla entered into an agreement with America’s Gilead Sciences, which owns the patent for the drug, granting it a licence to manufacture and distribute the drug in 127 countries, including Kenya.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
Support Independent Journalism

Stand With Bold Journalism.
Stand With The Standard.

Journalism can't be free because the truth demands investment. At The Standard, we invest time, courage and skills to bring you accurate, factual and impactful stories. Subscribe today and stand with us in the pursuit of credible journalism.

Pay via
M - PESA
VISA
Airtel Money
Secure Payment Kenya's most trusted newsroom since 1902